تاثیر نانو پارتیکل های کیتوزان در واکسن توکسوئیدی پنتاوالان کلستریدیایی با توجه به پاسخ-های ایمنولوژیک و کلینیکال پاتولوژی

AbdelAllah, N.H., Abdeltawab, N.F., Boseila, A.A., Amin, M.A., 2016. Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model. Evid Based Complement Alternat Med 2016, 7659684.

Ahmed, T.A., Aljaeid, B.M., 2016. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther 10, 483-507.

Arca, H.C., Gunbeyaz, M., Senel, S., 2009. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 8, 937-953.

Borrmann, E., Schulze, F., Cussler, K., Hanel, I., Diller, R., 2006. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin. Vet Microbiol 114, 41-50.

Caetano, L.A., Almeida, A.J., Goncalves, L.M., 2016. Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation. Mar Drugs 14, 90.

Cheung, R.C., Ng, T.B., Wong, J.H., Chan, W.Y., 2015. Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications. Mar Drugs 13, 5156-5186.

Dabaghian, M., Latifi, A.M., Tebianian, M., NajmiNejad, H., Ebrahimi, S.M., 2018. Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model. Vaccine 36, 2886-2895.

Delano, M.L., Mischler, S.A., Underwood, W.J., 2002. Biology and diseases of ruminants: sheep, goats, and cattle. Laboratory animal medicine, Elsevier, New York, pp. 519-614.

Draayer, H., 2011. Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use. Proc Vaccinol 5, 171-174.

Ebert, E., Oppling, V., Werner, E., Cussler, K., 1999. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines. FEMS Immunol Med Microbiol 24, 299-311.

Foumani, M., Asadpour, L., Azizi Saraji, A., Sharifat Salmani, A., Aghasadeghi, M., 2012. Adjuvants and their mechanisms of action. J Ardabil Univ Med Sci 12, 276-291.

Gerdts, V., 2015. Adjuvants for veterinary vaccines--types and modes of action. Berl Munch Tierarztl Wochenschr 128, 456-463.

Gong, Y., Tao, L., Wang, F., Liu, W., Jing, L., Liu, D., et al., 2015. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine. Mol Med Rep 12, 4123-4132.

Heffernan, M.J., Zaharoff, D.A., Fallon, J.K., Schlom, J., Greiner, J.W., 2011. In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials 32, 926-932.

Irvine, D.J., Hanson, M.C., Rakhra, K., Tokatlian, T., 2015. Synthetic Nanoparticles for Vaccines and Immunotherapy. Chem Rev 115, 11109-11146.

Islam, M.A., Firdous, J., Choi, Y.J., Yun, C.H., Cho, C.S., 2012. Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review. Int J Nanomedicine 7, 6077-6093.

Jamialahmadi, K., Behravan, J., Fathi Najafi, M., Tabatabaei Yazdi, M., Shahverdi, A., Faramarzi, M., 2011. Enzymatic production of N-acetyl-D-glucosamine from chitin using crude enzyme preparation of Aeromonas sp. PTCC1691. Biotechnology 10, 292-297.

Khalili, I., Ghadimipour, R., Sadigh Eteghad, S., Fathi Najafi, M., Ebrahimi, M.M., Godsian, N., et al., 2015. Evaluation of immune response against inactivated avian influenza (H9N2) vaccine, by using chitosan nanoparticles. Jundishapur J Microbiol 8, e27035.

Koppolu, B.P., Smith, S.G., Ravindranathan, S., Jayanthi, S., Suresh Kumar, T.K., Zaharoff, D.A., 2014. Controlling chitosan-based encapsulation for protein and vaccine delivery. Biomaterials 35, 4382-4389.

Kumar, M.N.R., 2000. A review of chitin and chitosan applications. React Functional Polymers 46, 1-27.

McGregor, D.P., Molloy, P.E., Cunningham, C., Harris, W.J., 1994. Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol Immunol 31, 219-226.

Neimert-Andersson, T., Hallgren, A.C., Andersson, M., Langeback, J., Zettergren, L., Nilsen-Nygaard, J., et al., 2011. Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine. Vaccine 29, 8965-8973.

Oliveira, C.R., Rezende, C.M., Silva, M.R., Pego, A.P., Borges, O., Goes, A.M., 2012. A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis. PLoS Negl Trop Dis 6, e1894.

Rezaee, M., Askari, G., EmamDjomeh, Z., Salami, M., 2018. Effect of organic additives on physiochemical properties and anti-oxidant release from chitosan-gelatin composite films to fatty food simulant. Int J Biol Macromol 114, 844-850.

Rezaei, M.A., Alonso, M., 2006. Preparation and evaluation of chitosan nanoparticles containing diphtheria toxoid as new carriers for nasal vaccine delivery in mice. Arch Razi Inst 61, 13-25.

Saleh, N., Fathalla, S.I., Nabil, R., Mosaad, A.A., 2011. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers. Anaerobe 17, 426-430.

Spickler, A.R., Roth, J.A., 2003. Adjuvants in veterinary vaccines: modes of action and adverse effects. J Vet Intern Med 17, 273-281.

Spinner, J.L., Oberoi, H.S., Yorgensen, Y.M., Poirier, D.S., Burkhart, D.J., Plante, M., et al., 2015. Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually. Vaccine 33, 5845-5853.

Zaharoff, D.A., Rogers, C.J., Hance, K.W., Schlom, J., Greiner, J.W., 2007. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 25, 2085-2094.

Zhao, K., Zhang, Y., Zhang, X., Li, W., Shi, C., Guo, C., et al., 2014. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Int J Nanomedicine 9, 389-402.